The Alberta Innovates - Health Solutions board is comprised of research, innovation and business leaders who share their expertise, insight and connections to encourage the development of new partnerships and empower people to find solutions to some of society's greatest challenges. For more information on this board, view the Board Competency Profile for Alberta Innovates - Health Solutions.
Mr. Seidel is the national Managing Partner of Davis LLP. He has extensive experience in all aspects of corporate and commercial law, real estate law, energy law, forestry law, commercial lending, and infrastructure and project finance. He works with clients in both the private and public sectors, providing legal and strategic business advice to executives, boards and elected officials. His practice also focuses on establishing board governance and accountability frameworks in the private and public sectors. He regularly provides opinions to elected and senior public officials relating to their obligations as representatives of government. He also provides opinions to all levels of government on other matters, including land assembly, natural resources and environmental matters.
Dr. Rajotte is currently Professor of Surgery and Medicine, Director of the Surgical-Medical Research Institute, and Director of the Islet Transplantation Group at the University of Alberta among other responsibilities. He was the founding Scientific Director of the Alberta Diabetes Institute at the University of Alberta. He is known as a pioneer in research related to islet transplantation for type 1 diabetes and has over 225 peer-reviewed published papers. Since 1986, he has supervised or co-supervised over 50 graduate students, 25 postdoctoral fellows, and numerous undergraduate students and summer students. He has received numerous honours and awards, including 2006 Alberta Order of Excellence and 2007 Member of the Order of Canada.
Mr. Best is the Chairman and CEO of Quikcard Group of Companies, a national company serving Canadians from offices in Western and Atlantic Canada, offering health plans, dental plans and medical benefits plans. He serves on numerous boards including the Canadian National Institute for the Blind and the Aaron Moser Spinal Cord Injury Foundation. He is also a member of the Institute of Corporate Directors. He is a Member of the Order of Canada and received the award of Edmonton Small Business Owner of the Year in 2008 from the Edmonton Chamber of Commerce.
Dr. Dolphin is Professor Emeritus with the University of British Columbia. He has administrative and research experience in industry, universities and non-governmental organizations. As the Vice-President Technology Development at Quadra Logic Technologies, he was instrumental in the discovery, development and commercialization of Visudyne, which has saved the vision of hundreds of thousands of people afflicted with "wet" age-related macular degeneration. He has served on numerous boards and is currently the Chair of Genome British Columbia. He has received several awards, including the Prix Galien in 2002 (along with Julia Levy). The Prix Galien has been described by the international pharmaceutical industry as the industry's equivalent of the Nobel Prize and the highest accolade for pharmaceutical research. He has been appointed an Officer of the Order of Canada.
Mrs. Mannix is the Chair and Patron of the Norlien Foundation, a private foundation with offices in Calgary and Edmonton. The Foundation, through the Alberta Family Wellness Initiative, is focused on creating alignments between science, policy and practice in the areas of brain development and its connection to addiction in order to bring about effective, comprehensive and integrated services for Alberta families. She has had a long career in the charitable sector and has worked for a number of organizations, including the Calgary Health Trust and the Canada West Foundation. She has also served on numerous boards including the Alberta Bone and Joint Health Institute. She has a Bachelor of Arts degree from the University of San Diego and a Juris Doctor degree from Seattle University.
Dr. Tingle is Professor Emeritus at the University of British Columbia and also Associate Director, Maternal, Infant, Child and Young Research Network. He was the President and CEO of the Michael Smith Foundation for Health Research from 2001-2008. His research efforts have principally been directed toward establishing a multi-disciplinary team of investigators interested in understanding the role played by persistent or "slow" virus infection in the pathogenesis of human disease. He has authored numerous research papers and presented at many conferences. He has received a number of awards including the BC Health Association Legacy Award (for significant contributions to the development of health policy, health leadership or healthcare governance).
Mr. Young is the President and Chief Executive Officer of Melcor Developments, a property development company. He has held various positions with the company since 1971. He is a member of a number of boards including the APEGGA Education Foundation, the Urban Development Institute and the Citadel Theatre.